Nifty
Sensex
:
:
22147.00
73088.33
151.15 (0.69%)
599.34 (0.83%)

Pharmaceuticals & Drugs

Rating :
49/99

BSE: 500259 | NSE: LYKALABS

128.85
19-Apr-2024
  • Open
  • High
  • Low
  • Previous Close
  •  128.35
  •  131.00
  •  125.00
  •  128.80
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  90964
  •  116.21
  •  144.30
  •  88.50

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 427.19
  • N/A
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 474.58
  • N/A
  • 6.08

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 54.81%
  • 5.78%
  • 33.91%
  • FII
  • DII
  • Others
  • 0.17%
  • 0.41%
  • 4.92%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 5.63
  • 2.57

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 76.53
  • -3.07

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 18.94
  • 4.58

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 4.42
  • 5.06
  • 15.11

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 99.00
  • 171.12
  • 14.95

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Mar 23
Mar 22
Var%
Net Sales
32.56
17.82
82.72%
27.99
25.53
9.64%
22.88
27.49
-16.77%
22.24
35.19
-36.80%
Expenses
25.70
15.60
64.74%
23.81
20.50
16.15%
20.23
21.19
-4.53%
18.94
22.58
-16.12%
EBITDA
6.86
2.21
210.41%
4.18
5.03
-16.90%
2.64
6.30
-58.10%
3.30
12.60
-73.81%
EBIDTM
21.08%
12.42%
14.94%
19.70%
11.56%
22.92%
14.82%
35.82%
Other Income
0.54
1.06
-49.06%
0.25
1.19
-78.99%
0.38
0.72
-47.22%
0.43
0.53
-18.87%
Interest
1.28
3.08
-58.44%
1.19
3.03
-60.73%
1.35
2.91
-53.61%
2.85
2.99
-4.68%
Depreciation
2.84
3.47
-18.16%
3.60
3.62
-0.55%
3.47
3.59
-3.34%
3.47
9.46
-63.32%
PBT
3.29
-10.29
-
-0.79
-0.64
-
-1.80
0.76
-
-3.00
-2.11
-
Tax
1.27
0.23
452.17%
-0.18
-0.30
-
0.13
0.05
160.00%
0.00
12.88
-100.00%
PAT
2.01
-10.52
-
-0.62
-0.34
-
-1.93
0.71
-
-3.00
-14.99
-
PATM
6.18%
-59.06%
-2.20%
-1.34%
-8.44%
2.58%
-13.47%
-42.60%
EPS
0.54
-3.63
-
-0.15
-0.13
-
-0.56
0.21
-
-0.98
-5.25
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Jun 15
Jun 14
Net Sales
105.67
93.07
194.08
86.25
61.49
70.78
59.81
110.08
130.41
166.27
118.86
Net Sales Growth
-0.34%
-52.05%
125.02%
40.27%
-13.13%
18.34%
-45.67%
-15.59%
-21.57%
39.89%
 
Cost Of Goods Sold
40.82
37.55
52.97
37.97
35.79
39.25
29.38
53.85
70.43
90.74
64.14
Gross Profit
64.85
55.52
141.11
48.28
25.70
31.54
30.43
56.23
59.98
75.53
54.72
GP Margin
61.37%
59.65%
72.71%
55.98%
41.80%
44.56%
50.88%
51.08%
45.99%
45.43%
46.04%
Total Expenditure
88.68
76.23
92.94
66.57
65.16
72.68
63.36
87.31
110.25
137.62
110.32
Power & Fuel Cost
-
3.60
3.92
2.94
2.56
2.28
1.86
1.90
1.39
2.06
3.11
% Of Sales
-
3.87%
2.02%
3.41%
4.16%
3.22%
3.11%
1.73%
1.07%
1.24%
2.62%
Employee Cost
-
18.61
18.06
14.57
13.86
14.69
16.98
17.24
14.71
17.26
16.39
% Of Sales
-
20.00%
9.31%
16.89%
22.54%
20.75%
28.39%
15.66%
11.28%
10.38%
13.79%
Manufacturing Exp.
-
5.09
4.20
3.00
1.73
1.32
1.06
1.20
1.24
1.93
1.46
% Of Sales
-
5.47%
2.16%
3.48%
2.81%
1.86%
1.77%
1.09%
0.95%
1.16%
1.23%
General & Admin Exp.
-
7.89
6.29
4.31
5.70
5.91
5.81
5.96
6.62
7.42
5.90
% Of Sales
-
8.48%
3.24%
5.00%
9.27%
8.35%
9.71%
5.41%
5.08%
4.46%
4.96%
Selling & Distn. Exp.
-
2.59
5.75
2.65
2.27
5.17
2.95
0.37
8.61
13.20
11.03
% Of Sales
-
2.78%
2.96%
3.07%
3.69%
7.30%
4.93%
0.34%
6.60%
7.94%
9.28%
Miscellaneous Exp.
-
0.90
1.74
1.14
3.24
4.07
5.31
6.80
7.25
5.00
11.03
% Of Sales
-
0.97%
0.90%
1.32%
5.27%
5.75%
8.88%
6.18%
5.56%
3.01%
6.97%
EBITDA
16.98
16.84
101.14
19.68
-3.67
-1.90
-3.55
22.77
20.16
28.65
8.54
EBITDA Margin
16.07%
18.09%
52.11%
22.82%
-5.97%
-2.68%
-5.94%
20.68%
15.46%
17.23%
7.18%
Other Income
1.60
3.40
2.09
1.56
3.09
2.09
2.13
2.24
2.06
2.35
5.37
Interest
6.67
11.87
20.13
25.94
20.07
7.17
9.58
18.72
16.42
25.57
28.53
Depreciation
13.38
14.15
17.35
8.32
8.01
7.31
11.28
10.25
9.32
10.87
8.80
PBT
-2.30
-5.78
65.77
-13.02
-28.66
-14.29
-22.28
-3.97
-3.52
-5.44
-23.43
Tax
1.22
-0.02
20.80
-4.05
0.74
-9.07
-1.04
-1.51
-0.19
1.06
1.25
Tax Rate
-53.04%
0.15%
35.11%
28.62%
-1.20%
58.78%
5.19%
18.62%
-4.86%
-28.96%
-30.79%
PAT
-3.54
-13.21
39.00
-11.55
-60.54
-5.55
-17.21
-5.54
3.69
-4.95
-6.59
PAT before Minority Interest
-3.57
-13.15
38.44
-10.09
-62.62
-6.35
-19.00
-6.60
4.09
-4.72
-5.30
Minority Interest
-0.03
-0.06
0.56
-1.46
2.08
0.80
1.79
1.06
-0.40
-0.23
-1.29
PAT Margin
-3.35%
-14.19%
20.09%
-13.39%
-98.46%
-7.84%
-28.77%
-5.03%
2.83%
-2.98%
-5.54%
PAT Growth
0.00%
-
-
-
-
-
-
-
-
-
 
EPS
-1.07
-3.99
11.78
-3.49
-18.29
-1.68
-5.20
-1.67
1.11
-1.50
-1.99

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Jun 15
Jun 14
Shareholder's Funds
45.44
13.34
-25.80
-14.34
43.02
49.47
37.71
45.24
43.06
52.71
Share Capital
30.69
28.69
28.69
28.69
28.14
28.14
22.04
23.13
22.67
22.67
Total Reserves
-2.69
-15.35
-54.49
-43.03
14.12
20.57
15.67
22.11
20.07
30.05
Non-Current Liabilities
73.25
72.77
148.88
136.67
72.28
5.28
38.68
28.52
36.95
65.16
Secured Loans
0.39
0.86
150.65
125.45
78.39
4.06
34.93
25.31
28.92
50.33
Unsecured Loans
63.40
61.63
0.71
0.64
0.90
0.87
0.84
0.00
0.00
7.67
Long Term Provisions
2.44
3.47
3.66
3.86
4.08
3.63
4.39
2.92
4.30
4.20
Current Liabilities
32.60
99.35
49.88
66.32
84.81
167.12
165.45
162.83
195.24
208.09
Trade Payables
9.41
12.00
14.71
18.85
23.23
24.21
39.16
42.08
54.64
63.26
Other Current Liabilities
14.35
66.24
23.10
30.83
43.31
92.38
73.07
56.55
79.41
77.72
Short Term Borrowings
7.64
20.07
10.37
14.41
16.26
45.82
50.23
59.95
59.85
66.20
Short Term Provisions
1.20
1.05
1.70
2.23
2.02
4.72
2.99
4.26
1.35
0.91
Total Liabilities
151.52
185.61
173.66
187.88
202.85
225.23
248.87
240.50
278.76
329.26
Net Block
68.10
93.96
98.19
104.78
107.73
116.04
132.90
104.23
121.64
162.45
Gross Block
157.96
177.35
202.50
188.36
202.81
155.31
144.01
200.41
213.51
248.18
Accumulated Depreciation
89.87
83.40
104.31
83.58
95.08
39.27
11.11
96.18
91.87
85.73
Non Current Assets
107.32
133.42
144.59
152.00
167.75
176.16
186.07
158.70
177.08
211.17
Capital Work in Progress
16.23
17.74
25.76
27.76
31.07
27.88
24.23
30.17
27.03
21.78
Non Current Investment
0.04
0.01
0.01
0.01
0.01
0.23
0.26
0.39
0.32
0.30
Long Term Loans & Adv.
22.96
21.71
20.63
19.46
28.94
32.01
28.69
23.92
28.09
26.65
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
44.20
52.20
29.08
35.88
35.11
49.07
62.79
81.81
101.69
118.09
Current Investments
0.01
0.01
0.01
0.01
0.01
0.00
0.00
0.00
0.00
0.00
Inventories
6.95
8.20
4.31
6.73
7.00
11.20
13.24
10.81
19.25
15.83
Sundry Debtors
20.13
18.45
8.67
8.04
14.63
20.50
29.17
43.29
56.70
68.02
Cash & Bank
11.71
17.05
7.15
10.30
1.71
2.43
5.12
5.56
6.51
10.71
Other Current Assets
5.41
2.87
4.73
6.54
11.77
14.95
15.25
22.14
19.23
23.54
Short Term Loans & Adv.
2.48
5.62
4.21
4.26
9.64
13.21
10.92
17.22
14.57
18.24
Net Current Assets
11.61
-47.15
-20.80
-30.44
-49.70
-118.05
-102.66
-81.03
-93.55
-90.00
Total Assets
151.52
185.62
173.67
187.88
202.86
225.23
248.86
240.51
278.77
329.26

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Jun 15
Jun 14
Cash From Operating Activity
8.95
79.25
8.81
5.32
26.67
10.88
31.38
11.95
26.54
89.10
PBT
-13.17
59.25
-14.14
-61.88
-15.42
-20.04
-8.10
3.69
-4.95
-6.59
Adjustment
31.78
41.93
35.40
55.76
15.17
20.79
30.53
16.15
31.64
32.87
Changes in Working Capital
-9.86
-21.01
-11.64
10.94
27.65
10.36
10.10
-7.57
-0.79
66.90
Cash after chg. in Working capital
8.75
80.16
9.62
4.82
27.39
11.10
32.53
12.27
25.90
93.17
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
0.20
-0.92
-0.81
0.50
-1.10
-0.44
-1.20
-0.33
-0.10
1.02
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.37
0.23
0.06
0.00
0.74
-5.10
Cash From Investing Activity
7.35
-6.17
-0.16
-0.11
-3.97
-3.17
-12.67
17.29
28.99
-56.87
Net Fixed Assets
19.80
-2.28
-20.42
-43.81
-2.41
-3.63
12.94
-4.69
29.40
-9.46
Net Investments
0.00
0.00
0.00
30.05
-0.01
0.00
0.12
0.00
-0.04
-42.31
Others
-12.45
-3.89
20.26
13.65
-1.55
0.46
-25.73
21.98
-0.37
-5.10
Cash from Financing Activity
-21.64
-63.18
-11.80
3.38
-23.42
-10.41
-19.15
-30.19
-59.72
-26.32
Net Cash Inflow / Outflow
-5.34
9.90
-3.15
8.60
-0.72
-2.69
-0.43
-0.96
-4.20
5.91
Opening Cash & Equivalents
17.05
7.15
10.30
1.71
2.43
5.12
5.56
6.51
10.71
4.80
Closing Cash & Equivalent
11.71
17.05
7.15
10.30
1.70
2.43
5.12
5.56
6.51
10.71

Financial Ratios

Consolidated /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Jun 15
Jun 14
Book Value (Rs.)
9.12
4.65
-8.99
-5.00
15.02
16.78
15.82
16.94
14.99
18.55
ROA
-7.80%
21.40%
-5.58%
-32.05%
-2.97%
-8.02%
-2.70%
1.58%
-1.55%
-1.72%
ROE
-63.63%
0.00%
0.00%
-448.65%
-14.20%
-46.30%
-18.27%
11.74%
-13.05%
-11.06%
ROCE
-1.00%
56.68%
8.95%
-31.39%
-5.50%
-6.52%
6.66%
12.41%
11.73%
11.93%
Fixed Asset Turnover
0.56
1.02
0.44
0.31
0.40
0.41
0.68
0.65
0.75
0.57
Receivable days
75.65
25.51
35.37
67.29
90.56
149.54
113.31
136.29
132.10
204.83
Inventory Days
29.71
11.76
23.36
40.77
46.92
73.58
37.61
40.97
37.15
49.11
Payable days
104.00
92.01
161.35
117.58
127.84
181.43
174.53
168.94
158.77
188.04
Cash Conversion Cycle
1.36
-54.74
-102.62
-9.53
9.65
41.69
-23.60
8.32
10.48
65.90
Total Debt/Equity
2.58
9.76
-6.30
-9.85
2.28
2.39
3.60
3.12
4.05
3.97
Interest Cover
-0.11
3.94
0.45
-2.08
-1.15
-1.09
0.57
1.24
0.86
0.86

News Update:


  • Lyka Labs - Quarterly Results
    8th Feb 2024, 13:44 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.